The germline inactivating variants in the primary MMR genes (MSH2, MLH1, MSH6, PMS2, and EPCAM) have been associated with the hereditary cancer syndrome, the Lynch syndrome (LS). The gene discussed is MRC1; the disease is Inherited cancer-predisposing syndrome.